The Prader-Willi syndrome (PWS) market is anticipated to experience significant growth in the coming years, fueled by rising diagnosis rates and the impending launch of innovative therapies. This rare genetic disorder affects individuals from birth, presenting challenges in areas such as muscle tone, development, and behavior, often leading to obesity if left unmanaged. This report delves into the current treatment landscape, emerging drugs, market dynamics, and future growth projections for the PWS market.
